SCHEMBL25797396

SCHEMBL25797396

COc1cccc(C)c1-c1ccccc1[P@@](=O)(c1ccccc1)c1ccccc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.45
MEN1 O00255 6/20 0.45
HTT P42858 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
TOP1 P11387 1/20 0.38
ALDH1A1 P00352 5/20 0.38
MAPT P10636 4/20 0.38
APAF1 O14727 1/20 0.38
MITF O75030 1/20 0.38
LMNA P02545 1/20 0.38
ELANE P08246 2/20 0.37
KDM4E B2RXH2 1/20 0.37
USP2 O75604 1/20 0.37
DUSP3 P51452 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
POLB P06746 2/20 0.37
NPSR1 Q6W5P4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25797530 0.95 KMT2A (0.48) KMT2AMEN1HTTL3MBTL1CYP1A2
SCHEMBL23658930 0.86 KMT2A (0.52) KMT2AMEN1HTTL3MBTL1TOP1
SCHEMBL25798214 0.86 KMT2A (0.52) KMT2AMEN1HTTL3MBTL1TOP1
SCHEMBL15715191 0.86 KMT2A (0.52) KMT2AMEN1HTTL3MBTL1TOP1
SCHEMBL5572022 0.84 KMT2A (0.50) KMT2AMEN1HTTL3MBTL1TOP1
SCHEMBL10177309 0.78 MEN1 (0.44) KMT2AMEN1HTTCYP1A2CYP3A4
SCHEMBL5715738 0.78 KMT2A (0.51) KMT2AMEN1HTTL3MBTL1CYP3A4
SCHEMBL31212640 0.77 NPSR1 (0.44) KMT2AMEN1HTTL3MBTL1ALDH1A1
SCHEMBL2552588 0.77 NPSR1 (0.44) KMT2AMEN1HTTL3MBTL1ALDH1A1
SCHEMBL15711847 0.77 KMT2A (0.47) KMT2AMEN1HTTL3MBTL1TOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212204-A1 REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS THE SCRIPPS RESEARCH INSTITUTE 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212204-A1 REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS PNKP, POLL, RNGTT KMT2A 2666/4885MEN1 2014/4885HTT 3532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.